{"SLR NAME":"Effect of convalescent blood products for patients with severe acute respiratory infections of viral etiology: a systematic review, meta-analysis and meta-regression","References":[{"title1":"Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study","References":[{"title2":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?","References":[]},{"title2":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection","References":[{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"},{"title3":"Convalescent%20plasma%20treatment%20reduced%20mortality%20in%20patients%20with%20severe%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20infection"}]},{"title2":"Critical care services and 2009 H1N1 influenza in Australia and New Zealand","References":[{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"}]},{"title2":"Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome","References":[]},{"title2":"Critically ill patients with 2009 influenza A(H1N1) in Mexico","References":[]},{"title2":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada","References":[{"title3":"Critically%20ill%20patients%20with%202009%20influenza%20A(H1N1)%20infection%20in%20Canada"},{"title3":"Critically%20ill%20patients%20with%202009%20influenza%20A(H1N1)%20infection%20in%20Canada"},{"title3":"Critically%20ill%20patients%20with%202009%20influenza%20A(H1N1)%20infection%20in%20Canada"},{"title3":"Critically%20ill%20patients%20with%202009%20influenza%20A(H1N1)%20infection%20in%20Canada"},{"title3":"Critically%20ill%20patients%20with%202009%20influenza%20A(H1N1)%20infection%20in%20Canada"},{"title3":"Critically%20ill%20patients%20with%202009%20influenza%20A(H1N1)%20infection%20in%20Canada"},{"title3":"Critically%20ill%20patients%20with%202009%20influenza%20A(H1N1)%20infection%20in%20Canada"},{"title3":"Critically%20ill%20patients%20with%202009%20influenza%20A(H1N1)%20infection%20in%20Canada"},{"title3":"Critically%20ill%20patients%20with%202009%20influenza%20A(H1N1)%20infection%20in%20Canada"},{"title3":"Critically%20ill%20patients%20with%202009%20influenza%20A(H1N1)%20infection%20in%20Canada"},{"title3":"Critically%20ill%20patients%20with%202009%20influenza%20A(H1N1)%20infection%20in%20Canada"},{"title3":"Critically%20ill%20patients%20with%202009%20influenza%20A(H1N1)%20infection%20in%20Canada"},{"title3":"Critically%20ill%20patients%20with%202009%20influenza%20A(H1N1)%20infection%20in%20Canada"},{"title3":"Critically%20ill%20patients%20with%202009%20influenza%20A(H1N1)%20infection%20in%20Canada"},{"title3":"Critically%20ill%20patients%20with%202009%20influenza%20A(H1N1)%20infection%20in%20Canada"},{"title3":"Critically%20ill%20patients%20with%202009%20influenza%20A(H1N1)%20infection%20in%20Canada"},{"title3":"Critically%20ill%20patients%20with%202009%20influenza%20A(H1N1)%20infection%20in%20Canada"},{"title3":"Critically%20ill%20patients%20with%202009%20influenza%20A(H1N1)%20infection%20in%20Canada"},{"title3":"Critically%20ill%20patients%20with%202009%20influenza%20A(H1N1)%20infection%20in%20Canada"},{"title3":"Critically%20ill%20patients%20with%202009%20influenza%20A(H1N1)%20infection%20in%20Canada"},{"title3":"Critically%20ill%20patients%20with%202009%20influenza%20A(H1N1)%20infection%20in%20Canada"},{"title3":"Critically%20ill%20patients%20with%202009%20influenza%20A(H1N1)%20infection%20in%20Canada"},{"title3":"Critically%20ill%20patients%20with%202009%20influenza%20A(H1N1)%20infection%20in%20Canada"}]},{"title2":"APACHE II: a severity of disease classification system","References":[]},{"title2":"PRISM III: an updated pediatric risk of mortality score","References":[]},{"title2":"MERS-CoV: clinical decision making support for treatment","References":[]},{"title2":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis","References":[{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"}]},{"title2":"Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection","References":[]},{"title2":"End points for testing influenza antiviral treatments for patients at high risk of severe and life-threatening disease","References":[]},{"title2":"Association of oseltamivir treatment with virus shedding, illness, and household transmission of influenza viruses","References":[]},{"title2":"Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection","References":[]}]},{"title1":"Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection","References":[{"title2":"Dexamethasone in hospitalized patients with Covid-19","References":[{"title3":"Dexamethasone%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Dexamethasone%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Dexamethasone%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Dexamethasone%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Dexamethasone%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Dexamethasone%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Dexamethasone%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Dexamethasone%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Dexamethasone%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Dexamethasone%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Dexamethasone%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Dexamethasone%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Dexamethasone%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Dexamethasone%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Dexamethasone%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Dexamethasone%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Dexamethasone%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Dexamethasone%20in%20hospitalized%20patients%20with%20Covid-19"},{"title3":"Dexamethasone%20in%20hospitalized%20patients%20with%20Covid-19"}]},{"title2":"Beigel, J. H. et al. Remdesivir for the treatment of Covid-19 : final report. N. Engl. J. Med.10.1056/NEJMoa2007764 (2020).","References":[]},{"title2":"Repurposed antiviral drugs for COVID-19 : interim WHO SOLIDARITY trial results. WHO Solidarity Trial Consortium","References":[]},{"title2":"Study assessing the safety, tolerability, pharmacokinetics, and immunogenicity of repeated subcutaneous doses of anti-spike (S) SARS-CoV-2 monoclonal antibodies (REGN10933+REGN10987) in adult volunteers as related to COVID-19, https://clinicaltrials.gov/ct2/show/study/NCT04519437?term=Regeneron+Pharmaceuticals&amp;cond=%22Coronavirus+Infections%22&amp;draw=2&amp;rank=2#wrapper (accessed 20 October 2020).","References":[]},{"title2":"Safety, tolerability, and efficacy of anti-spike (S) SARS-CoV-2 monoclonal antibodies for the treatment of ambulatory adult patients with COVID-19, https://clinicaltrials.gov/ct2/show/NCT04425629?term=Regeneron+Pharmaceuticals&amp;cond=%22Coronavirus+Infections%22&amp;draw=2&amp;rank=3 (accessed 20 October 2020).","References":[]},{"title2":"Safety, tolerability, and efficacy of anti-spike (S) SARS-CoV-2 monoclonal antibodies for hospitalized adult patients with COVID-19, https://clinicaltrials.gov/ct2/show/NCT04426695?term=Regeneron+Pharmaceuticals&amp;cond=%22Coronavirus+Infections%22&amp;draw=2&amp;rank=4 (accessed 20 October 2020).","References":[]},{"title2":"Neutralization of virus infectivity by antibodies: old problems in new perspectives","References":[{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"},{"title3":"Neutralization%20of%20virus%20infectivity%20by%20antibodies:%20old%20problems%20in%20new%20perspectives"}]},{"title2":"Neutralizing antibodies for the treatment of COVID-19","References":[]},{"title2":"Carrillo, J. et al. Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity. Biochem. Biophys. Res. Commun. 10.1016/j.bbrc.2020.10.108 (2020).","References":[]},{"title2":"Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia","References":[{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"},{"title3":"Feasibility%20of%20using%20convalescent%20plasma%20immunotherapy%20for%20MERS-CoV%20infection,%20Saudi%20Arabia"}]},{"title2":"Use of convalescent plasma therapy in SARS patients in Hong Kong","References":[{"title3":"Use%20of%20convalescent%20plasma%20therapy%20in%20SARS%20patients%20in%20Hong%20Kong"},{"title3":"Use%20of%20convalescent%20plasma%20therapy%20in%20SARS%20patients%20in%20Hong%20Kong"},{"title3":"Use%20of%20convalescent%20plasma%20therapy%20in%20SARS%20patients%20in%20Hong%20Kong"},{"title3":"Use%20of%20convalescent%20plasma%20therapy%20in%20SARS%20patients%20in%20Hong%20Kong"},{"title3":"Use%20of%20convalescent%20plasma%20therapy%20in%20SARS%20patients%20in%20Hong%20Kong"},{"title3":"Use%20of%20convalescent%20plasma%20therapy%20in%20SARS%20patients%20in%20Hong%20Kong"},{"title3":"Use%20of%20convalescent%20plasma%20therapy%20in%20SARS%20patients%20in%20Hong%20Kong"},{"title3":"Use%20of%20convalescent%20plasma%20therapy%20in%20SARS%20patients%20in%20Hong%20Kong"},{"title3":"Use%20of%20convalescent%20plasma%20therapy%20in%20SARS%20patients%20in%20Hong%20Kong"},{"title3":"Use%20of%20convalescent%20plasma%20therapy%20in%20SARS%20patients%20in%20Hong%20Kong"},{"title3":"Use%20of%20convalescent%20plasma%20therapy%20in%20SARS%20patients%20in%20Hong%20Kong"},{"title3":"Use%20of%20convalescent%20plasma%20therapy%20in%20SARS%20patients%20in%20Hong%20Kong"}]},{"title2":"Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection","References":[]},{"title2":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis","References":[{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"},{"title3":"The%20effectiveness%20of%20convalescent%20plasma%20and%20hyperimmune%20immunoglobulin%20for%20the%20treatment%20of%20severe%20acute%20respiratory%20infections%20of%20viral%20etiology:%20a%20systematic%20review%20and%20exploratory%20meta-analysis"}]},{"title2":"Haagmans, B. L. et al. SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a hamster model. Preprint at bioRxiv10.1101/2020.08.24.264630 (2020).","References":[]},{"title2":"Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis","References":[]},{"title2":"Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review","References":[{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"}]},{"title2":"Joyner, M. J. et al. Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience. Preprint at medRxivhttps://www.medrxiv.org/content/10.1101/2020.08.12.20169359v1 (2020).","References":[]},{"title2":"Li, L. et al. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial. JAMA324, 1-11 (2020).","References":[]},{"title2":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma","References":[]},{"title2":"Treatment with convalescent plasma for critically ill patients with severe acute respiratory syndrome coronavirus 2 infection","References":[{"title3":"Treatment%20with%20convalescent%20plasma%20for%20critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20infection"},{"title3":"Treatment%20with%20convalescent%20plasma%20for%20critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20infection"},{"title3":"Treatment%20with%20convalescent%20plasma%20for%20critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20infection"},{"title3":"Treatment%20with%20convalescent%20plasma%20for%20critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20infection"},{"title3":"Treatment%20with%20convalescent%20plasma%20for%20critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20infection"},{"title3":"Treatment%20with%20convalescent%20plasma%20for%20critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20infection"},{"title3":"Treatment%20with%20convalescent%20plasma%20for%20critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20infection"},{"title3":"Treatment%20with%20convalescent%20plasma%20for%20critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20infection"},{"title3":"Treatment%20with%20convalescent%20plasma%20for%20critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20infection"},{"title3":"Treatment%20with%20convalescent%20plasma%20for%20critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20infection"},{"title3":"Treatment%20with%20convalescent%20plasma%20for%20critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20infection"},{"title3":"Treatment%20with%20convalescent%20plasma%20for%20critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20infection"},{"title3":"Treatment%20with%20convalescent%20plasma%20for%20critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20infection"},{"title3":"Treatment%20with%20convalescent%20plasma%20for%20critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20infection"},{"title3":"Treatment%20with%20convalescent%20plasma%20for%20critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20infection"},{"title3":"Treatment%20with%20convalescent%20plasma%20for%20critically%20ill%20patients%20with%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20infection"}]},{"title2":"COVID-19 expanded access program, https://www.uscovidplasma.org/ (accessed 29 July 2020).","References":[]},{"title2":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","References":[{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"},{"title3":"Effectiveness%20of%20convalescent%20plasma%20therapy%20in%20severe%20COVID-19%20patients"}]},{"title2":"Joyner, M. J. et al. Early safety indicators of COVID-19 convalescent plasma in 5,000 patients. J. Clin. Invest.130, 4791-4797 (2020).","References":[]},{"title2":"Convalescent plasma treatment of severe COVID-19: a matched control study","References":[{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"},{"title3":"Convalescent%20plasma%20treatment%20of%20severe%20COVID-19:%20a%20matched%20control%20study"}]},{"title2":"Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter interventional trial","References":[]},{"title2":"Pau, A. K. et al. Convalescent plasma for the treatment of COVID-19: perspectives of the National Institutes of Health COVID-19 treatment guidelines panel. Ann. Intern. Med.174, 93-95 (2020).","References":[]},{"title2":"U.S. Food and Drug Administration. Convalescent Plasma Letter of Authorization, August 2020, https://www.fda.gov/media/141477/download (accessed 6 September 2020).","References":[]},{"title2":"The Dutch National Institute for Public Health and Environment. COVID-19 Guideline (only available in Dutch), https://lci.rivm.nl/richtlijnen/covid-19 (accessed 5 October 2020, last updated 5 October 2020).","References":[]},{"title2":"International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC). COVID-19 Report 19 May 2020, https://media.tghn.org/medialibrary/2020/05/ISARIC_Data_Platform_COVID-19_Report_19MAY20.pdf (accessed 27 May 2020).","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"}]},{"title2":"The effect of age on mortality in patients with COVID-19: a meta-analysis with 611,583 subjects","References":[{"title3":"The%20effect%20of%20age%20on%20mortality%20in%20patients%20with%20COVID-19:%20a%20meta-analysis%20with%20611,583%20subjects"},{"title3":"The%20effect%20of%20age%20on%20mortality%20in%20patients%20with%20COVID-19:%20a%20meta-analysis%20with%20611,583%20subjects"},{"title3":"The%20effect%20of%20age%20on%20mortality%20in%20patients%20with%20COVID-19:%20a%20meta-analysis%20with%20611,583%20subjects"},{"title3":"The%20effect%20of%20age%20on%20mortality%20in%20patients%20with%20COVID-19:%20a%20meta-analysis%20with%20611,583%20subjects"},{"title3":"The%20effect%20of%20age%20on%20mortality%20in%20patients%20with%20COVID-19:%20a%20meta-analysis%20with%20611,583%20subjects"},{"title3":"The%20effect%20of%20age%20on%20mortality%20in%20patients%20with%20COVID-19:%20a%20meta-analysis%20with%20611,583%20subjects"},{"title3":"The%20effect%20of%20age%20on%20mortality%20in%20patients%20with%20COVID-19:%20a%20meta-analysis%20with%20611,583%20subjects"},{"title3":"The%20effect%20of%20age%20on%20mortality%20in%20patients%20with%20COVID-19:%20a%20meta-analysis%20with%20611,583%20subjects"},{"title3":"The%20effect%20of%20age%20on%20mortality%20in%20patients%20with%20COVID-19:%20a%20meta-analysis%20with%20611,583%20subjects"},{"title3":"The%20effect%20of%20age%20on%20mortality%20in%20patients%20with%20COVID-19:%20a%20meta-analysis%20with%20611,583%20subjects"},{"title3":"The%20effect%20of%20age%20on%20mortality%20in%20patients%20with%20COVID-19:%20a%20meta-analysis%20with%20611,583%20subjects"},{"title3":"The%20effect%20of%20age%20on%20mortality%20in%20patients%20with%20COVID-19:%20a%20meta-analysis%20with%20611,583%20subjects"},{"title3":"The%20effect%20of%20age%20on%20mortality%20in%20patients%20with%20COVID-19:%20a%20meta-analysis%20with%20611,583%20subjects"},{"title3":"The%20effect%20of%20age%20on%20mortality%20in%20patients%20with%20COVID-19:%20a%20meta-analysis%20with%20611,583%20subjects"},{"title3":"The%20effect%20of%20age%20on%20mortality%20in%20patients%20with%20COVID-19:%20a%20meta-analysis%20with%20611,583%20subjects"},{"title3":"The%20effect%20of%20age%20on%20mortality%20in%20patients%20with%20COVID-19:%20a%20meta-analysis%20with%20611,583%20subjects"},{"title3":"The%20effect%20of%20age%20on%20mortality%20in%20patients%20with%20COVID-19:%20a%20meta-analysis%20with%20611,583%20subjects"},{"title3":"The%20effect%20of%20age%20on%20mortality%20in%20patients%20with%20COVID-19:%20a%20meta-analysis%20with%20611,583%20subjects"}]},{"title2":"Gender differences in patients with COVID-19: focus on severity and mortality","References":[{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"},{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"},{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"},{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"},{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"},{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"},{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"},{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"},{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"},{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"},{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"},{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"},{"title3":"Gender%20differences%20in%20patients%20with%20COVID-19:%20focus%20on%20severity%20and%20mortality"}]},{"title2":"C-reactive protein level may predict the risk of COVID-19 aggravation","References":[{"title3":"C-reactive%20protein%20level%20may%20predict%20the%20risk%20of%20COVID-19%20aggravation"},{"title3":"C-reactive%20protein%20level%20may%20predict%20the%20risk%20of%20COVID-19%20aggravation"},{"title3":"C-reactive%20protein%20level%20may%20predict%20the%20risk%20of%20COVID-19%20aggravation"},{"title3":"C-reactive%20protein%20level%20may%20predict%20the%20risk%20of%20COVID-19%20aggravation"},{"title3":"C-reactive%20protein%20level%20may%20predict%20the%20risk%20of%20COVID-19%20aggravation"},{"title3":"C-reactive%20protein%20level%20may%20predict%20the%20risk%20of%20COVID-19%20aggravation"},{"title3":"C-reactive%20protein%20level%20may%20predict%20the%20risk%20of%20COVID-19%20aggravation"},{"title3":"C-reactive%20protein%20level%20may%20predict%20the%20risk%20of%20COVID-19%20aggravation"},{"title3":"C-reactive%20protein%20level%20may%20predict%20the%20risk%20of%20COVID-19%20aggravation"},{"title3":"C-reactive%20protein%20level%20may%20predict%20the%20risk%20of%20COVID-19%20aggravation"},{"title3":"C-reactive%20protein%20level%20may%20predict%20the%20risk%20of%20COVID-19%20aggravation"},{"title3":"C-reactive%20protein%20level%20may%20predict%20the%20risk%20of%20COVID-19%20aggravation"},{"title3":"C-reactive%20protein%20level%20may%20predict%20the%20risk%20of%20COVID-19%20aggravation"},{"title3":"C-reactive%20protein%20level%20may%20predict%20the%20risk%20of%20COVID-19%20aggravation"},{"title3":"C-reactive%20protein%20level%20may%20predict%20the%20risk%20of%20COVID-19%20aggravation"}]},{"title2":"Risk factors for 2019 novel coronavirus disease (COVID-19) patients progressing to critical illness: a systematic review and meta-analysis","References":[{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Risk%20factors%20for%202019%20novel%20coronavirus%20disease%20(COVID-19)%20patients%20progressing%20to%20critical%20illness:%20a%20systematic%20review%20and%20meta-analysis"}]},{"title2":"Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a systemic review and meta-analysis","References":[{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"},{"title3":"Lymphopenia%20is%20associated%20with%20severe%20coronavirus%20disease%202019%20(COVID-19)%20infections:%20a%20systemic%20review%20and%20meta-analysis"}]},{"title2":"An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment","References":[{"title3":"An%20evaluation%20of%20COVID-19%20serological%20assays%20informs%20future%20diagnostics%20and%20exposure%20assessment"},{"title3":"An%20evaluation%20of%20COVID-19%20serological%20assays%20informs%20future%20diagnostics%20and%20exposure%20assessment"},{"title3":"An%20evaluation%20of%20COVID-19%20serological%20assays%20informs%20future%20diagnostics%20and%20exposure%20assessment"},{"title3":"An%20evaluation%20of%20COVID-19%20serological%20assays%20informs%20future%20diagnostics%20and%20exposure%20assessment"},{"title3":"An%20evaluation%20of%20COVID-19%20serological%20assays%20informs%20future%20diagnostics%20and%20exposure%20assessment"},{"title3":"An%20evaluation%20of%20COVID-19%20serological%20assays%20informs%20future%20diagnostics%20and%20exposure%20assessment"},{"title3":"An%20evaluation%20of%20COVID-19%20serological%20assays%20informs%20future%20diagnostics%20and%20exposure%20assessment"},{"title3":"An%20evaluation%20of%20COVID-19%20serological%20assays%20informs%20future%20diagnostics%20and%20exposure%20assessment"}]},{"title2":"Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): duration and key determinants","References":[{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"},{"title3":"Shedding%20of%20infectious%20virus%20in%20hospitalized%20patients%20with%20coronavirus%20disease-2019%20(COVID-19):%20duration%20and%20key%20determinants"}]},{"title2":"Virological assessment of hospitalized patients with COVID-2019","References":[]},{"title2":"Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)","References":[]},{"title2":"Passive immunity in the prevention of rabies","References":[]},{"title2":"Prevention of hepatitis B virus infection: from the past to the future","References":[]},{"title2":"Okba, N. M. A. et al. Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019 patients. Emerg. Infect. Dis.26, 1478-1488 (2020).","References":[]},{"title2":"Wang, X. et al. Neutralizing antibodies responses to SARS-CoV-2 in COVID-19 inpatients and convalescent patients. Clin. Infect. Dis. ciaa721 (2020).","References":[]},{"title2":"Horby, P. et al. Dexamethasone in hospitalized patients with Covid-19 : preliminary report. N. Engl. J. Med. 384, 693-704 (2020).","References":[]},{"title2":"An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment","References":[{"title3":"An%20evaluation%20of%20COVID-19%20serological%20assays%20informs%20future%20diagnostics%20and%20exposure%20assessment"},{"title3":"An%20evaluation%20of%20COVID-19%20serological%20assays%20informs%20future%20diagnostics%20and%20exposure%20assessment"},{"title3":"An%20evaluation%20of%20COVID-19%20serological%20assays%20informs%20future%20diagnostics%20and%20exposure%20assessment"},{"title3":"An%20evaluation%20of%20COVID-19%20serological%20assays%20informs%20future%20diagnostics%20and%20exposure%20assessment"},{"title3":"An%20evaluation%20of%20COVID-19%20serological%20assays%20informs%20future%20diagnostics%20and%20exposure%20assessment"},{"title3":"An%20evaluation%20of%20COVID-19%20serological%20assays%20informs%20future%20diagnostics%20and%20exposure%20assessment"},{"title3":"An%20evaluation%20of%20COVID-19%20serological%20assays%20informs%20future%20diagnostics%20and%20exposure%20assessment"},{"title3":"An%20evaluation%20of%20COVID-19%20serological%20assays%20informs%20future%20diagnostics%20and%20exposure%20assessment"}]},{"title2":"Long, Q.-X. et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat. Med.10.1038/s41591-020-0965-6 (2020).","References":[]},{"title2":"Petkova, E., Antman, E. M. &amp; Troxel, A. B. Pooling data from individual clinical trials in the COVID-19 era. JAMA, 10.1001/jama.2020.13042 (2020).","References":[]},{"title2":"Brouwer, P. J. M. et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science369, 643-650 (2020).","References":[]},{"title2":"A human monoclonal antibody blocking SARS-CoV-2 infection","References":[]},{"title2":"University of Oxford. RECOVERY Trial, https://www.recoverytrial.net/ (accessed 31 July 2020).","References":[]},{"title2":"REMAP-CAP, https://www.remapcap.org/ (accessed 31 July 2020).","References":[]},{"title2":"Convalescent plasma antibody levels and the risk of death from Covid-19","References":[{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"},{"title3":"Convalescent%20plasma%20antibody%20levels%20and%20the%20risk%20of%20death%20from%20Covid-19"}]},{"title2":"Convalescent plasma to limit SARS-CoV-2 associated complications, https://clinicaltrials.gov/ct2/show/NCT04373460?term=sullivan&amp;cond=covid&amp;draw=2&amp;rank=1 (accessed 31 July 2020).","References":[]},{"title2":"World Health Organizatin. Blueprint Novel Coronavirus COVID-19 Therapeutic Trial Synopsis, https://www.who.int/publications/i/item/covid-19-therapeutic-trial-synopsis (2020).","References":[]},{"title2":"The Dutch General Practicioner Association. Flu Vaccination: General Practicioner Guideline (only available in Dutch), https://www.nhg.org/sites/default/files/content/nhg_org/uploads/final_griep_sep_2020.pdf (accessed 19 October 2020).","References":[]},{"title2":"A proportional hazards model for the subdistribution of a competing risk","References":[]}]},{"title1":"Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)","References":[{"title2":"SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy","References":[]},{"title2":"Convalescent plasma in Covid-19: Possible mechanisms of action","References":[{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"},{"title3":"Convalescent%20plasma%20in%20Covid-19:%20Possible%20mechanisms%20of%20action"}]},{"title2":"Hark back: passive immunotherapy for influenza and other serious infections","References":[]},{"title2":"Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea","References":[{"title3":"Evaluation%20of%20Convalescent%20Plasma%20for%20Ebola%20Virus%20Disease%20in%20Guinea"},{"title3":"Evaluation%20of%20Convalescent%20Plasma%20for%20Ebola%20Virus%20Disease%20in%20Guinea"},{"title3":"Evaluation%20of%20Convalescent%20Plasma%20for%20Ebola%20Virus%20Disease%20in%20Guinea"},{"title3":"Evaluation%20of%20Convalescent%20Plasma%20for%20Ebola%20Virus%20Disease%20in%20Guinea"},{"title3":"Evaluation%20of%20Convalescent%20Plasma%20for%20Ebola%20Virus%20Disease%20in%20Guinea"},{"title3":"Evaluation%20of%20Convalescent%20Plasma%20for%20Ebola%20Virus%20Disease%20in%20Guinea"},{"title3":"Evaluation%20of%20Convalescent%20Plasma%20for%20Ebola%20Virus%20Disease%20in%20Guinea"},{"title3":"Evaluation%20of%20Convalescent%20Plasma%20for%20Ebola%20Virus%20Disease%20in%20Guinea"},{"title3":"Evaluation%20of%20Convalescent%20Plasma%20for%20Ebola%20Virus%20Disease%20in%20Guinea"},{"title3":"Evaluation%20of%20Convalescent%20Plasma%20for%20Ebola%20Virus%20Disease%20in%20Guinea"},{"title3":"Evaluation%20of%20Convalescent%20Plasma%20for%20Ebola%20Virus%20Disease%20in%20Guinea"},{"title3":"Evaluation%20of%20Convalescent%20Plasma%20for%20Ebola%20Virus%20Disease%20in%20Guinea"},{"title3":"Evaluation%20of%20Convalescent%20Plasma%20for%20Ebola%20Virus%20Disease%20in%20Guinea"},{"title3":"Evaluation%20of%20Convalescent%20Plasma%20for%20Ebola%20Virus%20Disease%20in%20Guinea"},{"title3":"Evaluation%20of%20Convalescent%20Plasma%20for%20Ebola%20Virus%20Disease%20in%20Guinea"}]},{"title2":"Use of convalescent plasma therapy in SARS patients in Hong Kong","References":[{"title3":"Use%20of%20convalescent%20plasma%20therapy%20in%20SARS%20patients%20in%20Hong%20Kong"},{"title3":"Use%20of%20convalescent%20plasma%20therapy%20in%20SARS%20patients%20in%20Hong%20Kong"},{"title3":"Use%20of%20convalescent%20plasma%20therapy%20in%20SARS%20patients%20in%20Hong%20Kong"},{"title3":"Use%20of%20convalescent%20plasma%20therapy%20in%20SARS%20patients%20in%20Hong%20Kong"},{"title3":"Use%20of%20convalescent%20plasma%20therapy%20in%20SARS%20patients%20in%20Hong%20Kong"},{"title3":"Use%20of%20convalescent%20plasma%20therapy%20in%20SARS%20patients%20in%20Hong%20Kong"},{"title3":"Use%20of%20convalescent%20plasma%20therapy%20in%20SARS%20patients%20in%20Hong%20Kong"},{"title3":"Use%20of%20convalescent%20plasma%20therapy%20in%20SARS%20patients%20in%20Hong%20Kong"},{"title3":"Use%20of%20convalescent%20plasma%20therapy%20in%20SARS%20patients%20in%20Hong%20Kong"},{"title3":"Use%20of%20convalescent%20plasma%20therapy%20in%20SARS%20patients%20in%20Hong%20Kong"},{"title3":"Use%20of%20convalescent%20plasma%20therapy%20in%20SARS%20patients%20in%20Hong%20Kong"},{"title3":"Use%20of%20convalescent%20plasma%20therapy%20in%20SARS%20patients%20in%20Hong%20Kong"}]},{"title2":"Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis","References":[]},{"title2":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","References":[{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"},{"title3":"Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals"}]},{"title2":"Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma","References":[]},{"title2":"Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study","References":[{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"},{"title3":"Clinical%20efficacy%20of%20convalescent%20plasma%20for%20treatment%20of%20COVID-19%20infections:%20Results%20of%20a%20multicenter%20clinical%20study"}]},{"title2":"Use of convalescent plasma in hospitalized patients with COVID-19: case series","References":[{"title3":"Use%20of%20convalescent%20plasma%20in%20hospitalized%20patients%20with%20COVID-19:%20case%20series"},{"title3":"Use%20of%20convalescent%20plasma%20in%20hospitalized%20patients%20with%20COVID-19:%20case%20series"},{"title3":"Use%20of%20convalescent%20plasma%20in%20hospitalized%20patients%20with%20COVID-19:%20case%20series"},{"title3":"Use%20of%20convalescent%20plasma%20in%20hospitalized%20patients%20with%20COVID-19:%20case%20series"},{"title3":"Use%20of%20convalescent%20plasma%20in%20hospitalized%20patients%20with%20COVID-19:%20case%20series"},{"title3":"Use%20of%20convalescent%20plasma%20in%20hospitalized%20patients%20with%20COVID-19:%20case%20series"},{"title3":"Use%20of%20convalescent%20plasma%20in%20hospitalized%20patients%20with%20COVID-19:%20case%20series"},{"title3":"Use%20of%20convalescent%20plasma%20in%20hospitalized%20patients%20with%20COVID-19:%20case%20series"},{"title3":"Use%20of%20convalescent%20plasma%20in%20hospitalized%20patients%20with%20COVID-19:%20case%20series"},{"title3":"Use%20of%20convalescent%20plasma%20in%20hospitalized%20patients%20with%20COVID-19:%20case%20series"},{"title3":"Use%20of%20convalescent%20plasma%20in%20hospitalized%20patients%20with%20COVID-19:%20case%20series"},{"title3":"Use%20of%20convalescent%20plasma%20in%20hospitalized%20patients%20with%20COVID-19:%20case%20series"},{"title3":"Use%20of%20convalescent%20plasma%20in%20hospitalized%20patients%20with%20COVID-19:%20case%20series"},{"title3":"Use%20of%20convalescent%20plasma%20in%20hospitalized%20patients%20with%20COVID-19:%20case%20series"},{"title3":"Use%20of%20convalescent%20plasma%20in%20hospitalized%20patients%20with%20COVID-19:%20case%20series"},{"title3":"Use%20of%20convalescent%20plasma%20in%20hospitalized%20patients%20with%20COVID-19:%20case%20series"},{"title3":"Use%20of%20convalescent%20plasma%20in%20hospitalized%20patients%20with%20COVID-19:%20case%20series"},{"title3":"Use%20of%20convalescent%20plasma%20in%20hospitalized%20patients%20with%20COVID-19:%20case%20series"},{"title3":"Use%20of%20convalescent%20plasma%20in%20hospitalized%20patients%20with%20COVID-19:%20case%20series"},{"title3":"Use%20of%20convalescent%20plasma%20in%20hospitalized%20patients%20with%20COVID-19:%20case%20series"},{"title3":"Use%20of%20convalescent%20plasma%20in%20hospitalized%20patients%20with%20COVID-19:%20case%20series"},{"title3":"Use%20of%20convalescent%20plasma%20in%20hospitalized%20patients%20with%20COVID-19:%20case%20series"},{"title3":"Use%20of%20convalescent%20plasma%20in%20hospitalized%20patients%20with%20COVID-19:%20case%20series"},{"title3":"Use%20of%20convalescent%20plasma%20in%20hospitalized%20patients%20with%20COVID-19:%20case%20series"}]},{"title2":"Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion","References":[{"title3":"Improved%20clinical%20symptoms%20and%20mortality%20among%20patients%20with%20severe%20or%20critical%20COVID-19%20after%20convalescent%20plasma%20transfusion"},{"title3":"Improved%20clinical%20symptoms%20and%20mortality%20among%20patients%20with%20severe%20or%20critical%20COVID-19%20after%20convalescent%20plasma%20transfusion"},{"title3":"Improved%20clinical%20symptoms%20and%20mortality%20among%20patients%20with%20severe%20or%20critical%20COVID-19%20after%20convalescent%20plasma%20transfusion"},{"title3":"Improved%20clinical%20symptoms%20and%20mortality%20among%20patients%20with%20severe%20or%20critical%20COVID-19%20after%20convalescent%20plasma%20transfusion"},{"title3":"Improved%20clinical%20symptoms%20and%20mortality%20among%20patients%20with%20severe%20or%20critical%20COVID-19%20after%20convalescent%20plasma%20transfusion"},{"title3":"Improved%20clinical%20symptoms%20and%20mortality%20among%20patients%20with%20severe%20or%20critical%20COVID-19%20after%20convalescent%20plasma%20transfusion"},{"title3":"Improved%20clinical%20symptoms%20and%20mortality%20among%20patients%20with%20severe%20or%20critical%20COVID-19%20after%20convalescent%20plasma%20transfusion"},{"title3":"Improved%20clinical%20symptoms%20and%20mortality%20among%20patients%20with%20severe%20or%20critical%20COVID-19%20after%20convalescent%20plasma%20transfusion"},{"title3":"Improved%20clinical%20symptoms%20and%20mortality%20among%20patients%20with%20severe%20or%20critical%20COVID-19%20after%20convalescent%20plasma%20transfusion"},{"title3":"Improved%20clinical%20symptoms%20and%20mortality%20among%20patients%20with%20severe%20or%20critical%20COVID-19%20after%20convalescent%20plasma%20transfusion"},{"title3":"Improved%20clinical%20symptoms%20and%20mortality%20among%20patients%20with%20severe%20or%20critical%20COVID-19%20after%20convalescent%20plasma%20transfusion"},{"title3":"Improved%20clinical%20symptoms%20and%20mortality%20among%20patients%20with%20severe%20or%20critical%20COVID-19%20after%20convalescent%20plasma%20transfusion"},{"title3":"Improved%20clinical%20symptoms%20and%20mortality%20among%20patients%20with%20severe%20or%20critical%20COVID-19%20after%20convalescent%20plasma%20transfusion"},{"title3":"Improved%20clinical%20symptoms%20and%20mortality%20among%20patients%20with%20severe%20or%20critical%20COVID-19%20after%20convalescent%20plasma%20transfusion"},{"title3":"Improved%20clinical%20symptoms%20and%20mortality%20among%20patients%20with%20severe%20or%20critical%20COVID-19%20after%20convalescent%20plasma%20transfusion"},{"title3":"Improved%20clinical%20symptoms%20and%20mortality%20among%20patients%20with%20severe%20or%20critical%20COVID-19%20after%20convalescent%20plasma%20transfusion"},{"title3":"Improved%20clinical%20symptoms%20and%20mortality%20among%20patients%20with%20severe%20or%20critical%20COVID-19%20after%20convalescent%20plasma%20transfusion"},{"title3":"Improved%20clinical%20symptoms%20and%20mortality%20among%20patients%20with%20severe%20or%20critical%20COVID-19%20after%20convalescent%20plasma%20transfusion"}]},{"title2":"Joyner MJ, Bruno KA, Klassen SA, et al. Safety Update: COVID-19 Convalescent Plasma in 20 000 Hospitalized Patients. Mayo Clin Proc 2020 Jul 19; www.ncbi.nlm.nih.gov/pmc/articles/PMC7368917/ Accessed on 25 Aug 2020.","References":[]},{"title2":"Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial","References":[]},{"title2":"Convalescent Plasma for COVID-19. A randomized clinical trial.","References":[{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."},{"title3":"Convalescent%20Plasma%20for%20COVID-19.%20A%20randomized%20clinical%20trial."}]},{"title2":"Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review","References":[{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"},{"title3":"Convalescent%20plasma%20or%20hyperimmune%20immunoglobulin%20for%20people%20with%20COVID-19:%20a%20living%20systematic%20review"}]},{"title2":"An EU programme of COVID-19convalescent plasma collection and transfusion. https://ec.europa.eu/health/sites/health/files/blood_tissues_organs/docs/guidance_plasma_covid19_en.pdf Accessed on 17 Aug 2020.","References":[]},{"title2":"Guidelines on Clinical Management of COVID-19 v.3. Ministry of Health and Family Welfare; Government of India. 2020. www.mohfw.gov.in/pdf/ClinicalManagementProtocolforCOVID19.pdf Accessed on 25 Aug 2020.","References":[]},{"title2":"Department of Health and Family Welfare, Ministry of Health and Family Welfare. Government of India. Gazette of India. https://cdsco.gov.in/opencms/opencms/en/Notifications/Gazette-Notifications/ Accessed on 25 Aug 2020.","References":[]},{"title2":"Points to consider in the preparation and transfusion of COVID-19 convalescent plasma","References":[{"title3":"Points%20to%20consider%20in%20the%20preparation%20and%20transfusion%20of%20COVID-19%20convalescent%20plasma"},{"title3":"Points%20to%20consider%20in%20the%20preparation%20and%20transfusion%20of%20COVID-19%20convalescent%20plasma"},{"title3":"Points%20to%20consider%20in%20the%20preparation%20and%20transfusion%20of%20COVID-19%20convalescent%20plasma"}]},{"title2":"Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications.","References":[]},{"title2":"First isolation of SARS-CoV-2 from clinical samples in India","References":[{"title3":"First%20isolation%20of%20SARS-CoV-2%20from%20clinical%20samples%20in%20India"},{"title3":"First%20isolation%20of%20SARS-CoV-2%20from%20clinical%20samples%20in%20India"},{"title3":"First%20isolation%20of%20SARS-CoV-2%20from%20clinical%20samples%20in%20India"},{"title3":"First%20isolation%20of%20SARS-CoV-2%20from%20clinical%20samples%20in%20India"},{"title3":"First%20isolation%20of%20SARS-CoV-2%20from%20clinical%20samples%20in%20India"},{"title3":"First%20isolation%20of%20SARS-CoV-2%20from%20clinical%20samples%20in%20India"},{"title3":"First%20isolation%20of%20SARS-CoV-2%20from%20clinical%20samples%20in%20India"},{"title3":"First%20isolation%20of%20SARS-CoV-2%20from%20clinical%20samples%20in%20India"},{"title3":"First%20isolation%20of%20SARS-CoV-2%20from%20clinical%20samples%20in%20India"},{"title3":"First%20isolation%20of%20SARS-CoV-2%20from%20clinical%20samples%20in%20India"},{"title3":"First%20isolation%20of%20SARS-CoV-2%20from%20clinical%20samples%20in%20India"},{"title3":"First%20isolation%20of%20SARS-CoV-2%20from%20clinical%20samples%20in%20India"},{"title3":"First%20isolation%20of%20SARS-CoV-2%20from%20clinical%20samples%20in%20India"},{"title3":"First%20isolation%20of%20SARS-CoV-2%20from%20clinical%20samples%20in%20India"},{"title3":"First%20isolation%20of%20SARS-CoV-2%20from%20clinical%20samples%20in%20India"},{"title3":"First%20isolation%20of%20SARS-CoV-2%20from%20clinical%20samples%20in%20India"},{"title3":"First%20isolation%20of%20SARS-CoV-2%20from%20clinical%20samples%20in%20India"},{"title3":"First%20isolation%20of%20SARS-CoV-2%20from%20clinical%20samples%20in%20India"}]},{"title2":"A minimal common outcome measure set for COVID-19 clinical research","References":[{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"},{"title3":"A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research"}]},{"title2":"Adverse drug reactions: definitions, diagnosis, and management","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"}]},{"title2":"Computing adjusted risk ratios and risk differences in Stata","References":[]},{"title2":"Effect of convalescent plasma on mortality among hospitalized patients with covid-19: initial three-month experience.","References":[]},{"title2":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections","References":[]},{"title2":"Pragmatic Trials","References":[]},{"title2":"Khan J, Hizbullah M, Jain N. Coronavirus pandemic fuels black-market for plasma of recovered patients. India Today July 22, 2020. www.indiatoday.in/india/story/exclusive-coronavirus-pandemic-fuels-black-market-for-plasma-of-recovered-patients-1703332-2020-07-22 Accessed on 25 Aug 2020.","References":[]}]},{"title1":"Convalescent Plasma Treatment Reduced Mortality in Patients With Severe
Pandemic Influenza A (H1N1) 2009 Virus Infection","References":[{"title2":"Delayed decrease of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection","References":[]},{"title2":"Differences in the epidemiological characteristics and clinical outcomes of pandemic (H1N1) 2009 influenza, compared with seasonal influenza","References":[{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"},{"title3":"Differences%20in%20the%20epidemiological%20characteristics%20and%20clinical%20outcomes%20of%20pandemic%20(H1N1)%202009%20influenza,%20compared%20with%20seasonal%20influenza"}]},{"title2":"Comparison of adult patients hospitalised with pandemic (H1N1) 2009 influenza and seasonal influenza during the &quot;PROTECT&quot; phase of the pandemic response","References":[]},{"title2":"Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis","References":[]},{"title2":"Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California","References":[]},{"title2":"Critical care services and 2009 H1N1 influenza in Australia and New Zealand","References":[{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"},{"title3":"Critical%20care%20services%20and%202009%20H1N1%20influenza%20in%20Australia%20and%20New%20Zealand"}]},{"title2":"An epidemiological study of 1348 cases of pandemic H1N1 influenza admitted to Singapore hospitals from July to September 2009","References":[]},{"title2":"Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009","References":[]},{"title2":"Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China","References":[]},{"title2":"Concurrent comparison of epidemiology, clinical presentation outcome between adult patients suffering from the pandemic influenza A (H1N1) 2009 virus and seasonal influenza A virus infection","References":[{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"},{"title3":"Concurrent%20comparison%20of%20epidemiology,%20clinical%20presentation%20outcome%20between%20adult%20patients%20suffering%20from%20the%20pandemic%20influenza%20A%20(H1N1)%202009%20virus%20and%20seasonal%20influenza%20A%20virus%20infection"}]},{"title2":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus","References":[]},{"title2":"Intravenous zanamivir for patients with pneumonitis due to pandemic (H1N1) 2009 influenza virus","References":[]},{"title2":"The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza","References":[]},{"title2":"Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome","References":[]},{"title2":"Hark back: passive immunotherapy for influenza and other serious infections","References":[]},{"title2":"Treatment of Argentine hemorrhagic fever","References":[{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"},{"title3":"Treatment%20of%20Argentine%20hemorrhagic%20fever"}]},{"title2":"Parvovirus B19 infection in pediatric transplant patients","References":[{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"},{"title3":"Parvovirus%20B19%20infection%20in%20pediatric%20transplant%20patients"}]},{"title2":"Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital","References":[]},{"title2":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?","References":[]},{"title2":"Treatment with convalescent plasma for influenza A (H5N1) infection","References":[]},{"title2":"Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza","References":[]},{"title2":"Logistical feasibility and potential benefits of a population-wide passive-immunotherapy program during an influenza pandemic","References":[{"title3":"Logistical%20feasibility%20and%20potential%20benefits%20of%20a%20population-wide%20passive-immunotherapy%20program%20during%20an%20influenza%20pandemic"},{"title3":"Logistical%20feasibility%20and%20potential%20benefits%20of%20a%20population-wide%20passive-immunotherapy%20program%20during%20an%20influenza%20pandemic"},{"title3":"Logistical%20feasibility%20and%20potential%20benefits%20of%20a%20population-wide%20passive-immunotherapy%20program%20during%20an%20influenza%20pandemic"},{"title3":"Logistical%20feasibility%20and%20potential%20benefits%20of%20a%20population-wide%20passive-immunotherapy%20program%20during%20an%20influenza%20pandemic"},{"title3":"Logistical%20feasibility%20and%20potential%20benefits%20of%20a%20population-wide%20passive-immunotherapy%20program%20during%20an%20influenza%20pandemic"},{"title3":"Logistical%20feasibility%20and%20potential%20benefits%20of%20a%20population-wide%20passive-immunotherapy%20program%20during%20an%20influenza%20pandemic"},{"title3":"Logistical%20feasibility%20and%20potential%20benefits%20of%20a%20population-wide%20passive-immunotherapy%20program%20during%20an%20influenza%20pandemic"},{"title3":"Logistical%20feasibility%20and%20potential%20benefits%20of%20a%20population-wide%20passive-immunotherapy%20program%20during%20an%20influenza%20pandemic"},{"title3":"Logistical%20feasibility%20and%20potential%20benefits%20of%20a%20population-wide%20passive-immunotherapy%20program%20during%20an%20influenza%20pandemic"},{"title3":"Logistical%20feasibility%20and%20potential%20benefits%20of%20a%20population-wide%20passive-immunotherapy%20program%20during%20an%20influenza%20pandemic"},{"title3":"Logistical%20feasibility%20and%20potential%20benefits%20of%20a%20population-wide%20passive-immunotherapy%20program%20during%20an%20influenza%20pandemic"}]},{"title2":"Viral load in patients infected with pandemic H1N1 2009 influenza A virus","References":[]},{"title2":"The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment","References":[{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"},{"title3":"The%20natural%20viral%20load%20profile%20of%20patients%20with%20pandemic%202009%20influenza%20A(H1N1)%20and%20the%20effect%20of%20oseltamivir%20treatment"}]},{"title2":"Practical limitations of convalescent plasma collection: a case scenario in pandemic preparation for influenza A (H1N1) infection","References":[]},{"title2":"Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009","References":[]},{"title2":"Confirmation of the first Hong Kong case of human infection by novel swine origin influenza A (H1N1) virus diagnosed using ultrarapid, real-time reverse transcriptase PCR","References":[]},{"title2":"Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice","References":[{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"},{"title3":"Passive%20immunoprophylaxis%20and%20therapy%20with%20humanized%20monoclonal%20antibody%20specific%20for%20influenza%20A%20H5%20hemagglutinin%20in%20mice"}]},{"title2":"Acute renal impairment in coronavirus-associated severe acute respiratory syndrome","References":[{"title3":"Acute%20renal%20impairment%20in%20coronavirus-associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"Acute%20renal%20impairment%20in%20coronavirus-associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"Acute%20renal%20impairment%20in%20coronavirus-associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"Acute%20renal%20impairment%20in%20coronavirus-associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"Acute%20renal%20impairment%20in%20coronavirus-associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"Acute%20renal%20impairment%20in%20coronavirus-associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"Acute%20renal%20impairment%20in%20coronavirus-associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"Acute%20renal%20impairment%20in%20coronavirus-associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"Acute%20renal%20impairment%20in%20coronavirus-associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"Acute%20renal%20impairment%20in%20coronavirus-associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"Acute%20renal%20impairment%20in%20coronavirus-associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"Acute%20renal%20impairment%20in%20coronavirus-associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"Acute%20renal%20impairment%20in%20coronavirus-associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"Acute%20renal%20impairment%20in%20coronavirus-associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"Acute%20renal%20impairment%20in%20coronavirus-associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"Acute%20renal%20impairment%20in%20coronavirus-associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"Acute%20renal%20impairment%20in%20coronavirus-associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"Acute%20renal%20impairment%20in%20coronavirus-associated%20severe%20acute%20respiratory%20syndrome"}]},{"title2":"The infection attack rate and severity of 2009 pandemic influenza (H1N1) in Hong Kong","References":[]},{"title2":"Long-term immunogenicity of influenza vaccine among the elderly: risk factors for poor immune response and persistence","References":[]},{"title2":"Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China","References":[{"title3":"Oseltamivir-resistant%20influenza%20A%20pandemic%20(H1N1)%202009%20virus,%20Hong%20Kong,%20China"},{"title3":"Oseltamivir-resistant%20influenza%20A%20pandemic%20(H1N1)%202009%20virus,%20Hong%20Kong,%20China"},{"title3":"Oseltamivir-resistant%20influenza%20A%20pandemic%20(H1N1)%202009%20virus,%20Hong%20Kong,%20China"},{"title3":"Oseltamivir-resistant%20influenza%20A%20pandemic%20(H1N1)%202009%20virus,%20Hong%20Kong,%20China"},{"title3":"Oseltamivir-resistant%20influenza%20A%20pandemic%20(H1N1)%202009%20virus,%20Hong%20Kong,%20China"},{"title3":"Oseltamivir-resistant%20influenza%20A%20pandemic%20(H1N1)%202009%20virus,%20Hong%20Kong,%20China"},{"title3":"Oseltamivir-resistant%20influenza%20A%20pandemic%20(H1N1)%202009%20virus,%20Hong%20Kong,%20China"},{"title3":"Oseltamivir-resistant%20influenza%20A%20pandemic%20(H1N1)%202009%20virus,%20Hong%20Kong,%20China"},{"title3":"Oseltamivir-resistant%20influenza%20A%20pandemic%20(H1N1)%202009%20virus,%20Hong%20Kong,%20China"},{"title3":"Oseltamivir-resistant%20influenza%20A%20pandemic%20(H1N1)%202009%20virus,%20Hong%20Kong,%20China"},{"title3":"Oseltamivir-resistant%20influenza%20A%20pandemic%20(H1N1)%202009%20virus,%20Hong%20Kong,%20China"},{"title3":"Oseltamivir-resistant%20influenza%20A%20pandemic%20(H1N1)%202009%20virus,%20Hong%20Kong,%20China"},{"title3":"Oseltamivir-resistant%20influenza%20A%20pandemic%20(H1N1)%202009%20virus,%20Hong%20Kong,%20China"},{"title3":"Oseltamivir-resistant%20influenza%20A%20pandemic%20(H1N1)%202009%20virus,%20Hong%20Kong,%20China"}]},{"title2":"Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts","References":[{"title3":"Rapid%20selection%20of%20oseltamivir-%20and%20peramivir-resistant%20pandemic%20H1N1%20virus%20during%20therapy%20in%202%20immunocompromised%20hosts"},{"title3":"Rapid%20selection%20of%20oseltamivir-%20and%20peramivir-resistant%20pandemic%20H1N1%20virus%20during%20therapy%20in%202%20immunocompromised%20hosts"},{"title3":"Rapid%20selection%20of%20oseltamivir-%20and%20peramivir-resistant%20pandemic%20H1N1%20virus%20during%20therapy%20in%202%20immunocompromised%20hosts"},{"title3":"Rapid%20selection%20of%20oseltamivir-%20and%20peramivir-resistant%20pandemic%20H1N1%20virus%20during%20therapy%20in%202%20immunocompromised%20hosts"},{"title3":"Rapid%20selection%20of%20oseltamivir-%20and%20peramivir-resistant%20pandemic%20H1N1%20virus%20during%20therapy%20in%202%20immunocompromised%20hosts"},{"title3":"Rapid%20selection%20of%20oseltamivir-%20and%20peramivir-resistant%20pandemic%20H1N1%20virus%20during%20therapy%20in%202%20immunocompromised%20hosts"},{"title3":"Rapid%20selection%20of%20oseltamivir-%20and%20peramivir-resistant%20pandemic%20H1N1%20virus%20during%20therapy%20in%202%20immunocompromised%20hosts"},{"title3":"Rapid%20selection%20of%20oseltamivir-%20and%20peramivir-resistant%20pandemic%20H1N1%20virus%20during%20therapy%20in%202%20immunocompromised%20hosts"},{"title3":"Rapid%20selection%20of%20oseltamivir-%20and%20peramivir-resistant%20pandemic%20H1N1%20virus%20during%20therapy%20in%202%20immunocompromised%20hosts"},{"title3":"Rapid%20selection%20of%20oseltamivir-%20and%20peramivir-resistant%20pandemic%20H1N1%20virus%20during%20therapy%20in%202%20immunocompromised%20hosts"},{"title3":"Rapid%20selection%20of%20oseltamivir-%20and%20peramivir-resistant%20pandemic%20H1N1%20virus%20during%20therapy%20in%202%20immunocompromised%20hosts"},{"title3":"Rapid%20selection%20of%20oseltamivir-%20and%20peramivir-resistant%20pandemic%20H1N1%20virus%20during%20therapy%20in%202%20immunocompromised%20hosts"},{"title3":"Rapid%20selection%20of%20oseltamivir-%20and%20peramivir-resistant%20pandemic%20H1N1%20virus%20during%20therapy%20in%202%20immunocompromised%20hosts"},{"title3":"Rapid%20selection%20of%20oseltamivir-%20and%20peramivir-resistant%20pandemic%20H1N1%20virus%20during%20therapy%20in%202%20immunocompromised%20hosts"},{"title3":"Rapid%20selection%20of%20oseltamivir-%20and%20peramivir-resistant%20pandemic%20H1N1%20virus%20during%20therapy%20in%202%20immunocompromised%20hosts"}]},{"title2":"Identification of influenza A nucleoprotein as an antiviral target","References":[{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"},{"title3":"Identification%20of%20influenza%20A%20nucleoprotein%20as%20an%20antiviral%20target"}]},{"title2":"Host defense mechanisms against influenza virus: interaction of influenza virus with murine macrophages in vitro","References":[]},{"title2":"Neutralization of human respiratory syncytial virus infectivity by antibodies low molecular weight compounds targeted against the fusion (F) glycoprotein","References":[]}]},{"title1":"Retrospective comparison of convalescent plasma with continuing high?dose methylprednisolone treatment in SARS patients","References":[{"title2":"A major outbreak of severe acute respiratory syndrome in Hong Kong","References":[]},{"title2":"A novel coronavirus associated severe acute respiratory syndrome","References":[{"title3":"A%20novel%20coronavirus%20associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20severe%20acute%20respiratory%20syndrome"},{"title3":"A%20novel%20coronavirus%20associated%20severe%20acute%20respiratory%20syndrome"}]},{"title2":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","References":[]},{"title2":"Severe acute respiratory syndrome","References":[]},{"title2":"Update: severe acute respiratory syndrome","References":[{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"},{"title3":"Update:%20severe%20acute%20respiratory%20syndrome"}]},{"title2":"Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee","References":[]},{"title2":"Prospective study of the clinical progression and viral load of SARS associated coronavirus pneumonia in a community outbreak","References":[{"title3":"Prospective%20study%20of%20the%20clinical%20progression%20and%20viral%20load%20of%20SARS%20associated%20coronavirus%20pneumonia%20in%20a%20community%20outbreak"},{"title3":"Prospective%20study%20of%20the%20clinical%20progression%20and%20viral%20load%20of%20SARS%20associated%20coronavirus%20pneumonia%20in%20a%20community%20outbreak"},{"title3":"Prospective%20study%20of%20the%20clinical%20progression%20and%20viral%20load%20of%20SARS%20associated%20coronavirus%20pneumonia%20in%20a%20community%20outbreak"},{"title3":"Prospective%20study%20of%20the%20clinical%20progression%20and%20viral%20load%20of%20SARS%20associated%20coronavirus%20pneumonia%20in%20a%20community%20outbreak"},{"title3":"Prospective%20study%20of%20the%20clinical%20progression%20and%20viral%20load%20of%20SARS%20associated%20coronavirus%20pneumonia%20in%20a%20community%20outbreak"},{"title3":"Prospective%20study%20of%20the%20clinical%20progression%20and%20viral%20load%20of%20SARS%20associated%20coronavirus%20pneumonia%20in%20a%20community%20outbreak"},{"title3":"Prospective%20study%20of%20the%20clinical%20progression%20and%20viral%20load%20of%20SARS%20associated%20coronavirus%20pneumonia%20in%20a%20community%20outbreak"},{"title3":"Prospective%20study%20of%20the%20clinical%20progression%20and%20viral%20load%20of%20SARS%20associated%20coronavirus%20pneumonia%20in%20a%20community%20outbreak"},{"title3":"Prospective%20study%20of%20the%20clinical%20progression%20and%20viral%20load%20of%20SARS%20associated%20coronavirus%20pneumonia%20in%20a%20community%20outbreak"},{"title3":"Prospective%20study%20of%20the%20clinical%20progression%20and%20viral%20load%20of%20SARS%20associated%20coronavirus%20pneumonia%20in%20a%20community%20outbreak"},{"title3":"Prospective%20study%20of%20the%20clinical%20progression%20and%20viral%20load%20of%20SARS%20associated%20coronavirus%20pneumonia%20in%20a%20community%20outbreak"},{"title3":"Prospective%20study%20of%20the%20clinical%20progression%20and%20viral%20load%20of%20SARS%20associated%20coronavirus%20pneumonia%20in%20a%20community%20outbreak"},{"title3":"Prospective%20study%20of%20the%20clinical%20progression%20and%20viral%20load%20of%20SARS%20associated%20coronavirus%20pneumonia%20in%20a%20community%20outbreak"},{"title3":"Prospective%20study%20of%20the%20clinical%20progression%20and%20viral%20load%20of%20SARS%20associated%20coronavirus%20pneumonia%20in%20a%20community%20outbreak"},{"title3":"Prospective%20study%20of%20the%20clinical%20progression%20and%20viral%20load%20of%20SARS%20associated%20coronavirus%20pneumonia%20in%20a%20community%20outbreak"},{"title3":"Prospective%20study%20of%20the%20clinical%20progression%20and%20viral%20load%20of%20SARS%20associated%20coronavirus%20pneumonia%20in%20a%20community%20outbreak"},{"title3":"Prospective%20study%20of%20the%20clinical%20progression%20and%20viral%20load%20of%20SARS%20associated%20coronavirus%20pneumonia%20in%20a%20community%20outbreak"},{"title3":"Prospective%20study%20of%20the%20clinical%20progression%20and%20viral%20load%20of%20SARS%20associated%20coronavirus%20pneumonia%20in%20a%20community%20outbreak"}]}]}]}